Atricure stock

The Investor Relations website contains information about AtriCure, Inc.'s business for stockholders, potential investors, and financial analysts. AtriCure, Inc. Common Stock (ATRC) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.

View AtriCure, Inc. ATRC investment & stock information. Get the latest AtriCure, Inc. ATRC detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. AtriCure, Inc. Common Stock (ATRC) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Stock analysis for AtriCure Inc (ATRC:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Get breaking news and analysis on AtriCure, Inc. (ATRC) stock, price quote and chart, trading and investing tools. AtriCure Inc. company facts, information and stock details by MarketWatch. View atrc business summary and other industry information. AtriCure provides innovative atrial fibrillation (Afib) solutions designed to produce outcomes that reduce the economic and social burden of Afib.

AtriCure Inc. company facts, information and stock details by MarketWatch. View atrc business summary and other industry information.

AtriCure Inc. (NASDAQ:ATRC) SVP Justin J. Noznesky sold 29,134 shares of AtriCure stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $32.89, for a total transaction of $958,217.26. AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in the upcoming SVB Leerink 9th Annual Global Healthcare Conference in New York City. Today, AtriCure Inc. (NASDAQ:ATRC) stock received an upgrade by BTIG Research from Neutral to Buy. There are 5 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock. AtriCure, Inc () Stock Market infoRecommendations: Buy or sell AtriCure stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the AtriCure share forecasts, stock quote and buy / sell signals below.According to present data AtriCure's ATRC shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be ATRC - AtriCure Inc. Advanced Chart, Quote and financial news from the leading provider and award-winning BigCharts.com.

Interactive chart of historical stock value for AtriCure over the last 10 years. The value of a company is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. AtriCure market value as of March 05, 2020 is $1.52B .

AtriCure, Inc. Common Stock (ATRC) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. 7, 2020-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today  Real time AtriCure (ATRC) stock price quote, stock graph, news & analysis. The average AtriCure stock price for the last 52 weeks is 30.46. Compare ATRC With Other Stocks  Get breaking news and analysis on AtriCure, Inc. (ATRC) stock, price quote and chart, trading and investing tools. Real-time trade and investing ideas on AtriCure, Inc. ATRC from the largest community of traders and investors. Researching AtriCure (NASDAQ:ATRC) stock? View ATRC's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at 

AtriCure provides innovative atrial fibrillation (Afib) solutions designed to produce outcomes that reduce the economic and social burden of Afib.

Real time AtriCure (ATRC) stock price quote, stock graph, news & analysis. The average AtriCure stock price for the last 52 weeks is 30.46. Compare ATRC With Other Stocks 

AtriCure, Inc., is a medical device company. It develops, manufactures and sells cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart, tissue.

The Investor Relations website contains information about AtriCure, Inc.'s business for stockholders, potential investors, and financial analysts. AtriCure, Inc. Common Stock (ATRC) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. Buy shares of AtriCure Inc (ATRC) stock on Stash. Check out AtriCure Inc's stock price chart and stay up to date on the company. Invest in AtriCure Inc stock and others with any dollar amount. Stock quote for AtriCure, Inc. Common Stock Common Stock (ATRC) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq.

Reuters India provides latest news & articles on stock market quotes, online stock quotes, India. Get India stock market quotes, stock quote news india, latest share prices for ATRC.OQ AtriCure, Inc Stock Price Forecast, "ATRC" Predictons for2020 Atricure (ATRC) reports earnings on 5/19/2020. Shares are down 36.2% since reporting last quarter. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings. Find the latest AtriCure, Inc. (ATRC) stock quote, history, news and other vital information to help you with your stock trading and investing. AtriCure Inc. (NASDAQ:ATRC) SVP Justin J. Noznesky sold 29,134 shares of AtriCure stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $32.89, for a total transaction of $958,217.26. AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in the upcoming SVB Leerink 9th Annual Global Healthcare Conference in New York City.